Synlab AG (FRA:SYAB) Change In Receivables : €-1 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Synlab AG Change In Receivables?

Synlab AG's change in receivables for the quarter that ended in Mar. 2024 was €-40 Mil. It means Synlab AG's Accounts Receivable increased by €40 Mil from Dec. 2023 to Mar. 2024 .

Synlab AG's change in receivables for the fiscal year that ended in Dec. 2023 was €31 Mil. It means Synlab AG's Accounts Receivable declined by €31 Mil from Dec. 2022 to Dec. 2023 .

Synlab AG's Accounts Receivable for the quarter that ended in Mar. 2024 was €438 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Synlab AG's Days Sales Outstanding for the three months ended in Mar. 2024 was 58.52.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Synlab AG's liquidation value for the three months ended in Mar. 2024 was €-1,677 Mil.

Synlab AG Change In Receivables Historical Data

The historical data trend for Synlab AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synlab AG Change In Receivables Chart

Synlab AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Receivables

-267.46

-81.40

167.50

30.55

Synlab AG Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial											-8.55	8.23	19.18	11.70	-39.65

Synlab AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1 Mil.

Synlab AG (FRA:SYAB) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Synlab AG's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	437.672	/	682.421	*	91
=	58.52

2. In Ben Graham's calculation of liquidation value, Synlab AG's accounts receivable are only considered to be worth 75% of book value:

Synlab AG's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	300.468	-	2337.209	+	0.75 * 437.672	+	0.5 * 62.887
=	-1,677

Synlab AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of Synlab AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Synlab AG (FRA:SYAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Synlab AG (FRA:SYAB) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

SYAB:Germany

Address

Moosacher Strasse 88, Augsburg, BY, DEU, 80809

Website

https://www.synlab.de

Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for practising doctors, clinics, and patients. Its geographical segments include France; Germany; South and North and East. The company derives a majority of revenue from the North and East.

Synlab AG (FRA:SYAB) Headlines

No Headlines